Cervical cancer is the 4th most prevalent cancer among women, and the 7th most common cancer. MBLI provides HPV-related tetramers for use in research.
Cervical cancer is the fourth most common cancer affecting women: Antigen-Specific Detection of HPV and HSV
![Cervical cancer is the fourth most common cancer affecting women: Antigen-Specific Detection of HPV and HSV Cervical cancer is the fourth most common cancer affecting women: Antigen-Specific Detection of HPV and HSV](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/logo-1-600x300.png)